No Data
Crystal Amber's Portfolio Company Wins US Regulatory Nod for Diabetes Device Study Amendment
Crystal Amber Fund (CRS.L) said Tuesday that its investee company Morphic Medical received regulatory approval in the US for a study amendment for its diabetes treatment medical device Reset. The US F
Morphic to Participate in Jefferies Global Healthcare Conference
WALTHAM, Mass., May 31, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chron
Morphic Ethical Fund Continues Share Buy-Back
Morphic Ethical Fund Completes Share Buy-back
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
Morphic Demonstrates Novel Real-Time Visualization of Small Molecule Α4β7 Inhibition of Gut-Trafficking Cells
Supporting Materials: Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclona... Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclona...-α4